Print this page

Special Gazette, 21 August 2019

Contents 

  • Final Regulatory Decision for the reconsideration of methiocarb—4
  • Reasons for the affirmation of approvals—6
  • Annexure 1: Affirmed representative label components—9

Content last updated

Content last reviewed

URL

http://apvma.gov.au/node/53236
Was this page helpful?

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.